PD 0332991 HCl
- CAS No.
- 827022-32-2
- Chemical Name:
- PD 0332991 HCl
- Synonyms
- Palbociclib HCl;CS-365;PD 0332991 HCl;Palbociclib-025;Palbociclib-019-HCl;PD 0332991;PD-0332991;StemSelect PD 0332991;PD 0332991 hydrochloride;PD-0332991 (Palbociclib);PD 0332991 HCl USP/EP/BP
- CBNumber:
- CB22593007
- Molecular Formula:
- C24H30ClN7O2
- Molecular Weight:
- 484
- MDL Number:
- MFCD22420809
- MOL File:
- 827022-32-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| storage temp. | = -70C |
|---|---|
| solubility | ≥14.48 mg/mL in H2O; ≥2.42 mg/mL in DMSO; ≥2.79 mg/mL in EtOH with gentle warming and ultrasonic |
| form | Yellow liquid |
| color | Light yellow to yellow |
| Water Solubility | water: 10mg/mL |
| InChIKey | STEQOHNDWONVIF-UHFFFAOYSA-N |
| SMILES | O=C1C(=C(C)C2=CN=C(NC3N=CC(N4CCNCC4)=CC=3)N=C2N1C1CCCC1)C(=O)C.Cl |
| FDA UNII | BKC4F3Q5XL |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H315-H319 |
| Precautionary statements | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |
| WGK Germany | WGK 3 |
| HS Code | 29399990 |
| Storage Class | 11 - Combustible Solids |
PD 0332991 HCl price More Price(48)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | 5.30487 | StemSelect PD 0332991 - CAS 827022-32-2 - Calbiochem | 827022-32-2 | 5mg | $156 | 2026-04-30 | Buy |
| Cayman Chemical | 16273 | PD 0332991 (hydrochloride) ≥95% | 827022-32-2 | 1mg | $41 | 2026-04-30 | Buy |
| Cayman Chemical | 16273 | PD 0332991 (hydrochloride) ≥95% | 827022-32-2 | 5mg | $119 | 2026-04-30 | Buy |
| Cayman Chemical | 16273 | PD 0332991 (hydrochloride) ≥95% | 827022-32-2 | 10mg | $215 | 2026-04-30 | Buy |
| Cayman Chemical | 16273 | PD 0332991 (hydrochloride) ≥95% | 827022-32-2 | 25mg | $389 | 2026-04-30 | Buy |
PD 0332991 HCl Chemical Properties, Uses, Production
Description
PD 0332991 is an orally active, selective inhibitor of the cyclin D kinases Cdk4 (IC50 = 11 nM) and Cdk6 (IC50= 16 nM) with no activity against a panel of 36 additional protein kinases. It has been reported to have antiproliferative activity against retinoblastoma-positive tumor cells, blocking retinoblastoma phosphorylation and inducing G1 arrest at nanomolar concentrations. PD 0332991 can inhibit the growth of certain ER-positive or HER2-amplified breast cancer cells (IC50s as low as 4 nM) and demonstrates synergy with tamoxifen and trastuzumab, respectively. PD 0332991 inhibition of Cdk4 activity has been used to demonstrate a role for insulin-activated cyclinD1-Cdk4 signaling in the control of glucose metabolism that is independent of cell cycle progression.
Uses
PD 0332991 is an orally active, selective CDK4/6 inhibitor that blocks pRb phosphorylation at serine 780 and 795 in the low nanomolar range and is in clinical development for the treatment of solid tumors[3][4].
General Description
A cell-permeable, orally available and brain permeant, non-toxic pyridopyrimidinone compound that acts as a potent, selective, reversible, ATP competitive inhibitor of Cdk4 and Cdk6 (IC50 = 11, 9, and 15 nM for Cdk4/D1, Cdk4/D3 and Cdk6/D2, respectively). Hence, it reduces retinoblastoma protein phosphorylation at Ser780/Ser795 (IC50 = 66 nM in MDA-435 cells) and arrests cell cycle at G1 phase. Acts as a cytostatic agent, but does induce apoptotic cell death when used alone. However, it potentiates the cytotoxicity of dexamethasone (>Cat. No. 265005), bortezomib (>Cat. No. 504314), and tamoxifen (Cat. No. 579000) in estrogen receptor (ER)-positive cell lines. Exhibits only a trivial inhibitory activity towards Cdk2/E2, Cdk2/A, Cdk1/B and Cdk5/p25 in a 36-kinase panel (IC50 >10 μM). Improves endoderm differentiation of late G1-human embryonic stem cells expressing Smad2 or Smad3 (~ 750 nM) and further enhances endoderm differentiation into hepatic and pancreatic progenitor cells. Shown to regress the growth of human breast tumor xenografts in murine models (~150 mg/kg, p.o., daily).
Biochem/physiol Actions
Cell permeable: yes
Synthesis
571189-10-1
827022-32-2
Synthesis of 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride from tert-butyl 4-[6-[[8-cyclopentyl-6-(1-ethoxyethenyl)-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazin-1-carboxylate. [2,3-d]pyrimidin-7(8H)-one hydrochloride was prepared in the following general procedure: to tert-butyl 4-[6-[[8-cyclopentyl-6-(1-ethoxyvinyl)-5-methyl-7-oxo-7,8-dihydropyrido[2,3-D]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylate under ice-bath cooling conditions (4.50 g. 0.00783 mol, as prepared in Example 2) in a solution of dichloromethane (100 mL) was bubbled with hydrogen chloride gas. The resulting suspension was sealed and stirred overnight at room temperature and subsequently diluted with ether (200 mL). The solid was collected by filtration, washed with ether and dried to afford 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride as a yellow solid (4.01 g, 92% yield).
target
CDK4/cyclin D1
References
[1] ivan diaz-padilla, lillian l. siu and ignacio duran. cyclin-dependent kinase inhibitors as potential targeted anticancer agents. invest new drugs. 2009, 27: 586–594.
[2] richard s finn, judy dering, dylan conklin, ondrej kalous, david j cohen, amrita j desai, charles ginther, mohammad atefi, isan chen, camilla fowst, gerret los and dennis j slamon. pd 0332991, a selective cyclin d kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. breast cancer research. 2009, 11: r77.
[3]Nguyen, L., Zhong, W.-Z., Painter, C. L., Zhang, C., Rahavendran, S. V., & Shen, Z. (2010). Quantitative analysis of PD 0332991 in xenograft mouse tumor tissue by a 96-well supported liquid extraction format and liquid chromatography/mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 53(3), 228–234. https://doi.org/10.1016/j.jpba.2010.02.031
[4]Nemoto, A., Saida, S., Kato, I., Kikuchi, J., Furukawa, Y., Maeda, Y., Akahane, K., Honna-Oshiro, H., Goi, K., Kagami, K., Kimura, S., Sato, Y., Okabe, S., Niwa, A., Watanabe, K., Nakahata, T., Heike, T., Sugita, K., & Inukai, T. (2016). Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome–Positive Lymphoid Leukemia. Molecular Cancer Therapeutics, 15(1), 94–105. https://doi.org/10.1158/1535-7163.mct-14-1065


PD 0332991 HCl Preparation Products And Raw materials
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Wuhan Yingnuo Pharmaceutical Technology Co., Ltd. | +86-027-59232304 15387063101 | 1276242629@qq.com | China | 9977 | 58 |
| Taizhou Tongxin Bio-Tech Co., Ltd | 0523-86818997 18652728585 | sales@allyrise.com | China | 2986 | 60 |
| Shanghai Boyle Chemical Co., Ltd. | sales@boylechem.com | China | 2915 | 55 | |
| Nanbu County Chengxin Technology Co., Ltd. | 0838-5675166 15883665058 | nbcxkj@126.com | China | 956 | 55 |
| Energy Chemical | 400-0056266 | sales8178@energy-chemical.com | China | 44850 | 61 |
| JinYan Chemicals(ShangHai) Co.,Ltd. | 13817811078 | sales@jingyan-chemical.com | China | 9963 | 60 |
| Adamas Reagent, Ltd. | 400-6009262 15618770481 | yhx@titansci.com | China | 14098 | 59 |
| WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. | 17702719238 | sales@sun-shinechem.com | China | 1197 | 64 |
| Jinan Trio PharmaTech Co., Ltd. | 0531-88811783 | sales@trio-pharmatech.com | China | 1856 | 62 |
| Shanghai civi chemical technology co.,Ltd | 86-21-34053660 | sale@labgogo.com | China | 9853 | 52 |
View Latest Price from PD 0332991 HCl manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-09-02 | PD 0332991 HCl
827022-32-2
|
$1.20-31.00 | 1kg | 99% | Henan Fengda Chemical Co., Ltd | ||
![]() |
2026-08-20 | PD 0332991 HCl USP/EP/BP
827022-32-2
|
$1.10 | 1g | 99.9% | 100 Tons min | Dideu Industries Group Limited | |
![]() |
2026-07-03 | PD 0332991 HCl
827022-32-2
|
1kg | 98% | 1000kgs | Shaanxi Dideu New Materials Co. Ltd |
-

- PD 0332991 HCl
827022-32-2
- $1.20-31.00
- 99%
- Henan Fengda Chemical Co., Ltd
-

- PD 0332991 HCl USP/EP/BP
827022-32-2
- $1.10
- 99.9%
- Dideu Industries Group Limited
-

- PD 0332991 HCl
827022-32-2
- $0.00
- 98%
- Shaanxi Dideu New Materials Co. Ltd
827022-32-2 (PD 0332991 HCl) Related Search:
1of4





